Multiple Myeloma

被引:58
|
作者
Anderson, Kenneth C.
Alsina, Melissa [1 ]
Bensinger, William
Biermann, J. Sybil [2 ]
Chanan-Khan, Asher [3 ]
Cohen, Adam D. [4 ]
Devine, Steven [5 ,6 ]
Djulbegovic, Benjamin [1 ]
Faber, Edward A., Jr. [7 ]
Gasparetto, Cristina [8 ]
Huff, Carol Ann [9 ]
Kassim, Adetola [10 ]
Medeiros, Bruno C. [11 ]
Meredith, Ruby [12 ]
Raje, Noopur [13 ]
Schriber, Jeffrey [14 ]
Singhal, Seema [15 ]
Somlo, George
Stockerl-Goldstein, Keith [16 ,17 ]
Treon, Steven P.
Tricot, Guido [18 ]
Weber, Donna M. [19 ]
Yahalom, Joachim [20 ]
Yunus, Furhan
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Michigan Comprehens Canc Ctr, Ann Arbor, MI USA
[3] Roswell Pk Canc Inst, Buffalo, NY USA
[4] Fox Chase Canc Ctr, Philadelphia, PA USA
[5] Ohio State Univ Comprehens Canc Ctr James Canc Ho, Columbus, OH USA
[6] Solove Res Inst, Columbus, MS USA
[7] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE USA
[8] Duke Canc Inst, Durham, NC USA
[9] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Sidney, BC, Canada
[10] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[11] Stanford Canc Inst, Stanford, CA USA
[12] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[13] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[14] City Hope Comprehens Canc Ctr, Duarte, CA USA
[15] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA
[16] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA
[17] Washington Univ Sch Med, Washington, DC USA
[18] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[19] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[20] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2011年 / 9卷 / 10期
关键词
NCCN Clinical Practice Guidelines; NCCN Guidelines; multiple myeloma; Waldenstrom's monoclonal protein; C-reactive protein; combination chemotherapy; stem cell transplant; primary amyloidosis; cytogenetics; proteasome inhibitor; immunomodulatory drugs; bisphosphonates; supportive therapies; novel therapies; STEM-CELL TRANSPLANTATION; HIGH-DOSE THERAPY; THALIDOMIDE PLUS DEXAMETHASONE; DONOR LYMPHOCYTE INFUSIONS; PEGYLATED LIPOSOMAL DOXORUBICIN; NEWLY-DIAGNOSED MYELOMA; HIGH RESPONSE RATES; LONG-TERM SURVIVAL; PHASE-III; INTERGROUPE-FRANCOPHONE;
D O I
10.6004/jnccn.2011.0095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1146 / 1183
页数:38
相关论文
共 50 条
  • [41] Initial Therapeutic Approaches to Patients with Multiple Myeloma
    Berbari, Hadi E.
    Kumar, Shaji K.
    ADVANCES IN THERAPY, 2021, 38 (07) : 3694 - 3711
  • [42] Update on the role of lenalidomide in patients with multiple myeloma
    Holstein, Sarah A.
    Suman, Vera J.
    McCarthy, Philip L.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 175 - 190
  • [43] Multiple myeloma - current status and future directions
    Rasche, Leo
    Knop, Stefan
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 793 - 804
  • [44] Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma
    Kumar, Shaji K.
    Laubach, Jacob P.
    Giove, Thomas J.
    Quick, Maureen
    Neuwirth, Rachel
    Yung, Godwin
    Rajkumar, S. Vincent
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (05) : 756 - 763
  • [45] Old and new generation immunomodulatory drugs in multiple myeloma
    Derudas, Daniele
    Capraro, Francesca
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2020, 62 (04) : 207 - 219
  • [46] Old and new generation proteasome inhibitors in multiple myeloma
    Montefusco, Vittorio
    Mussetti, Alberto
    Salas, Maria Q.
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2020, 62 (04) : 193 - 206
  • [47] Emerging therapies for the treatment of relapsed or refractory multiple myeloma
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Anderson, Kenneth C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (01) : 1 - 15
  • [48] Immunotherapy for multiple myeloma: Current status and future directions
    Ayed, Ayed O.
    Chang, Lung-Ji
    Moreb, Jan S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 399 - 412
  • [49] Next-generation immunomodulatory drugs in multiple myeloma
    Suska, Anna
    Czerniuk, Maciej Rafal
    Jurczyszyn, Artur
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 791 - 802
  • [50] Multiple myeloma: improved outcomes with new therapeutic approaches
    Eshaghian, Shahrooz
    Berenson, James R.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2012, 6 (03) : 330 - 336